WO2007135518A3 - Use of choline-based preparations for the treatment of tinnitus - Google Patents

Use of choline-based preparations for the treatment of tinnitus Download PDF

Info

Publication number
WO2007135518A3
WO2007135518A3 PCT/IB2007/001273 IB2007001273W WO2007135518A3 WO 2007135518 A3 WO2007135518 A3 WO 2007135518A3 IB 2007001273 W IB2007001273 W IB 2007001273W WO 2007135518 A3 WO2007135518 A3 WO 2007135518A3
Authority
WO
WIPO (PCT)
Prior art keywords
tinnitus
choline
treatment
based preparations
preparations
Prior art date
Application number
PCT/IB2007/001273
Other languages
French (fr)
Other versions
WO2007135518A2 (en
Inventor
Massimo Ronchetti
Original Assignee
Artmed S R L
Massimo Ronchetti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artmed S R L, Massimo Ronchetti filed Critical Artmed S R L
Priority to EP07734581A priority Critical patent/EP2026786A2/en
Publication of WO2007135518A2 publication Critical patent/WO2007135518A2/en
Publication of WO2007135518A3 publication Critical patent/WO2007135518A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the use of compositions based on choline and polyunsaturated fatty acids which are useful in the prevention and treatment of tinnitus.
PCT/IB2007/001273 2006-05-16 2007-05-16 Use of choline-based preparations for the treatment of tinnitus WO2007135518A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07734581A EP2026786A2 (en) 2006-05-16 2007-05-16 Use of choline-based preparations for the treatment of tinnitus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000956A ITMI20060956A1 (en) 2006-05-16 2006-05-16 USE OF COLINA-BASED COMPOSITIONS FOR TINNITE TREATMENT
ITMI2006A000956 2006-05-16

Publications (2)

Publication Number Publication Date
WO2007135518A2 WO2007135518A2 (en) 2007-11-29
WO2007135518A3 true WO2007135518A3 (en) 2008-02-07

Family

ID=38610962

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001273 WO2007135518A2 (en) 2006-05-16 2007-05-16 Use of choline-based preparations for the treatment of tinnitus

Country Status (3)

Country Link
EP (1) EP2026786A2 (en)
IT (1) ITMI20060956A1 (en)
WO (1) WO2007135518A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
GB201609735D0 (en) * 2016-06-03 2016-07-20 Avexxin As Combination therapy
JP2019529555A (en) 2016-09-21 2019-10-17 アヴェクシン エーエス Pharmaceutical composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084882A1 (en) * 2003-03-27 2004-10-07 Suntory Limited Use of arachidonic acid for normalization of infradian rhythm

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084882A1 (en) * 2003-03-27 2004-10-07 Suntory Limited Use of arachidonic acid for normalization of infradian rhythm

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAKISHIMA K ET AL: "TREATMENT OF SENSORY-NEURAL DEAFNESS AND TINNITUS WITH A NUCLEIC ACID DERIVATIVE A CLINICAL EVALUATION OF CDP-CHOLINE BY A DOUBLE-BLIND METHOD", 1971, ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, ECV EDITIO CANTOR VERLAG, AULENDORF, DE, PAGE(S) 1343-1349, ISSN: 0004-4172, XP001002631 *

Also Published As

Publication number Publication date
ITMI20060956A1 (en) 2007-11-17
EP2026786A2 (en) 2009-02-25
WO2007135518A2 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
GB2459809A (en) Fatty acid formulations and methods of use thereof
MX336435B (en) Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions.
EP2136844A4 (en) Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
ZA200900388B (en) Compositions and methods for the treatment of mucositis
WO2008027991A3 (en) USE OF DPA(n-6) OILS IN INFANT FORMULA
EP2007210A4 (en) Compositions comprising mono and di esters of biologically-based 1.3-propanediol
WO2007095316A3 (en) Compositions and methods for oligonucleotide formulations
WO2012074930A3 (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2008036353A3 (en) Omega-3 diglyceride emulsions
WO2009099719A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
IL196282A0 (en) Compositions and methods for enhancing the efficacy of il-2 mediated immune responses
WO2007001851A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2010149895A3 (en) Extract of whole seeds of moringa sp., and use thereof in cosmetic and/or dermatological compositions
WO2009026574A3 (en) Immunogenic compositions and uses thereof
GB2444896B (en) Compositions comprising polyunsaturated fatty acids
EP2549997A4 (en) Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
CL2011000290A1 (en) Method for extracting long chain polyunsaturated fatty acids; Oil composition and its use in cosmetic or therapeutic treatment.
WO2008011272A3 (en) Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions
WO2008139261A3 (en) Omega-3 lipid compound
WO2009125409A3 (en) Fatty acid amides and uses thereof
IL195771A0 (en) Methods and immune modulatory nucleic acid compositions for preventing and treating disease
WO2006103638A3 (en) Topical pharmaceutical compositions of terbinafine and processes for their preparation
WO2007135518A3 (en) Use of choline-based preparations for the treatment of tinnitus
WO2011011706A3 (en) Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07734581

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007734581

Country of ref document: EP